4
Changes in Ownership
Passage BIO, Inc. Filed Acc 0001787297-22-000005
Options or other derivatives
- Chief Res. & Develop Officer acquired 157,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Salinas Eliseo Oreste Chief Res. & Develop Officer | 2022-02-10 | Grant or award · Stock Option (right to buy) | +157,500 | 157,500 | D | ||
Loading xslF345X03/primary_doc.xml…